Jan 08, 2025
5:2
For every 2 shares held, investors received 5. The price per share adjusted from $651.40 to $260.56.
The split itself did not change the total investment value.
Jagsonpal Pharmaceuticals Ltd. (BSE:JAGSNPHARM) operates in the Pharmaceuticals: generic industry.
Jagsonpal Pharmaceuticals Ltd. company overviewJagsonpal Pharmaceuticals Ltd.'s most recent stock split was on January 8, 2025. It was a 5-for-2 forward split, so shareholders received 5 shares for every 2 they held.
Jagsonpal Pharmaceuticals Ltd. (BSE:JAGSNPHARM) has split its stock 2 times: a 8-for-1 split on July 20, 2004 and a 5-for-2 split on January 8, 2025.
Jagsonpal Pharmaceuticals Ltd. has split its stock 2 times. This history records 2 forward splits between July 20, 2004 and January 8, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Jagsonpal Pharmaceuticals Ltd.'s 5-for-2 split on January 8, 2025, every 2 shares became 5 shares.
Jagsonpal Pharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on January 8, 2025, 1 year ago. Companies announce splits in advance, and any new BSE:JAGSNPHARM split will appear on this page.
Already premium?